» Articles » PMID: 17027228

Wnt-3a Utilizes a Novel Low Dose and Rapid Pathway That Does Not Require Casein Kinase 1-mediated Phosphorylation of Dvl to Activate Beta-catenin

Overview
Journal Cell Signal
Date 2006 Oct 10
PMID 17027228
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The current view of canonical Wnt signalling is that following Wnt binding to its receptors (Frizzled-Lrp5/6), dishevelled (Dvl) becomes hyperphosphorylated, and the signal is transduced to the APC-GSK3beta-axin-beta-catenin multiprotein complex, which subsequently dissociates. As a result beta-catenin is not phosphorylated, escapes proteosomal degradation and activates its target genes after translocation to the nucleus. Here, we analyzed the importance of the Wnt-3a-induced phosphorylation and shift in electrophoretic migration of Dvl (PS-Dvl) for the activation of beta-catenin. Analysis of Wnt-3a time- and dose-responses in a dopaminergic cell line showed that beta-catenin is activated rapidly (within minutes) and at a low dose of Wnt-3a (1 ng/ml). Surprisingly, PS-Dvl appeared only after 30 min and at greater doses (> or =20 ng/ml) of Wnt-3a. Moreover, we found that a casein kinase 1 inhibitor (D4476) or siRNA for casein kinase 1 delta/epsilon (CK1delta/epsilon) blocked the Wnt-3a-induced PS-Dvl. Interestingly, CK1 inhibition or siRNA for CK1delta/epsilon did not ablate the activation of beta-catenin by Wnt-3a, indicating that there is a PS-Dvl-independent path to activate beta-catenin. The increase in beta-catenin activation by Wnt-3a (PS-Dvl-dependent or -independent) were blocked by Dickkopf1 (Dkk1), suggesting that the effect of Wnt-3a is in both cases mediated by Lrp5/6 receptors. Thus, our results show that Wnt-3a rapidly induce a partial activation of beta-catenin in the absence of PS-Dvl at low doses, while at high doses induce a full activation of beta-catenin in a PS-Dvl-dependent manner.

Citing Articles

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Radaszkiewicz T, Noskova M, Gomoryova K, Vondalova Blanarova O, Radaszkiewicz K, Pickova M Elife. 2021; 10.

PMID: 34702444 PMC: 8550759. DOI: 10.7554/eLife.65759.


The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma.

Wang K, Qiu X, Zhao Y, Wang H, Chen L Cancer Biol Med. 2021; .

PMID: 34591416 PMC: 8958883. DOI: 10.20892/j.issn.2095-3941.2021.0306.


Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways?.

Micka M, Bryja V Handb Exp Pharmacol. 2021; 269:117-135.

PMID: 34382124 DOI: 10.1007/164_2021_527.


Proteomic analysis identifies the E3 ubiquitin ligase Pdzrn3 as a regulatory target of Wnt5a-Ror signaling.

Konopelski Snavely S, Susman M, Kunz R, Tan J, Srinivasan S, Cohen M Proc Natl Acad Sci U S A. 2021; 118(25).

PMID: 34135125 PMC: 8237634. DOI: 10.1073/pnas.2104944118.


Primary Cilia Formation Does Not Rely on WNT/β-Catenin Signaling.

Bernatik O, Paclikova P, Kotrbova A, Bryja V, cajanek L Front Cell Dev Biol. 2021; 9:623753.

PMID: 33718363 PMC: 7952446. DOI: 10.3389/fcell.2021.623753.